Russell Investments Group, Ltd. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 114 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$401,320
-27.7%
46,503
-13.3%
0.00%0.0%
Q2 2023$554,945
-29.8%
53,618
-26.4%
0.00%
-50.0%
Q1 2023$790,464
-3.2%
72,854
+0.1%
0.00%0.0%
Q4 2022$816,490
+37.0%
72,771
+23.4%
0.00%
+100.0%
Q3 2022$596,000
-0.3%
58,970
-10.9%
0.00%0.0%
Q2 2022$598,000
-12.1%
66,161
-7.1%
0.00%0.0%
Q1 2022$680,000
-45.1%
71,245
-36.5%
0.00%
-50.0%
Q4 2021$1,238,000
+147.1%
112,200
+65.0%
0.00%
+100.0%
Q3 2021$501,000
-57.9%
67,980
-17.1%
0.00%
-50.0%
Q2 2021$1,190,000
-33.0%
81,994
-5.9%
0.00%
-33.3%
Q1 2021$1,776,000
-3.1%
87,122
-15.6%
0.00%
-25.0%
Q4 2020$1,833,000
+9.6%
103,228
-8.8%
0.00%0.0%
Q3 2020$1,672,000
-17.1%
113,165
+17.7%
0.00%0.0%
Q2 2020$2,016,000
+5.9%
96,172
+16.8%
0.00%
-20.0%
Q1 2020$1,903,000
+683.1%
82,368
+776.3%
0.01%
Q4 2019$243,000
-61.7%
9,400
-49.2%
0.00%
-100.0%
Q3 2017$634,000
-25.8%
18,508
-13.8%
0.00%
-50.0%
Q2 2017$855,000
+58.0%
21,465
+46.1%
0.00%
+100.0%
Q1 2017$541,000
+16.6%
14,6880.0%0.00%0.0%
Q4 2016$464,00014,6880.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders